Brought to you by 
Definiens raises €15mm through Series D round
25 Jun 2014
Executive Summary
Definiens AG (digital pathology image analysis) raised €15mm through its Series D round. Wellington Partners and Gilde Healthcare co-led, and were joined by returning backers Cipio Partners and TVM Capital. Wellington takes a seat on the company’s board. Funds will go toward continued advancement of Definiens’ Tissue Phenomics digital biomarker image analysis platform, which is used by pathologists and drug development firms for oncology research. Definiens' previous financing activity includes an undisclosed amount raised in 2000, €2mm in 2006, and €10mm in 2012.
Deal Industry
- Biotechnology
- In Vitro Diagnostics
- Medical Devices
- Pharmaceuticals
- Research, Analytical Equipment & Supplies
- Services
-
Medical Devices
-
Diagnostic Imaging Equipment & Supplies
- Digital Imaging
-
Diagnostic Imaging Equipment & Supplies
-
Laboratory Testing Services
- Anatomical Pathology
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Definiens raises €15mm through Series D round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice